ResearcherWhitehead Institute for Biomedical ResearchActive in the last 2 years
David R Pease
Matched on ORCID iD 0000-0002-0472-1900; OpenAlex author ID A5078806970; NIH RePORTER profile ID 12347806. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 2
- Labs led
- 0
- Collaborators
- 21
2023: 1 paper · 2024: 1 grant · 2025: 2 papers · 2026: 1 grant
Papers 3
- Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells. Co-author DOI 10.1073/pnas.2424051122↗
- Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. Co-author DOI 10.1172/jci.insight.187799↗
- SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer. Co-author DOI 10.1042/bcj20220439↗
Grants 2
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Renzo Emanuel Vera · 3 shared papers, 2023–2025 · strength 0.55
- Paper Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells. DOI 10.1073/pnas.2424051122↗
- Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
- Paper SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer. DOI 10.1042/bcj20220439↗
- Martín E. Fernández-Zapico · 3 shared papers, 2023–2025 · strength 0.55
- Paper Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells. DOI 10.1073/pnas.2424051122↗
- Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
- Paper SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer. DOI 10.1042/bcj20220439↗
- Noemí Manero‐Rupérez · 1 shared paper, 2025 · strength 0.20
- Judith Vinaixa · 1 shared paper, 2025 · strength 0.20
- Patricia Santofimia‐Castaño · 1 shared paper, 2025 · strength 0.20
- Neus Martínez‐Bosch · 1 shared paper, 2025 · strength 0.20
- Pilar Navarro · 1 shared paper, 2025 · strength 0.20
- Juan Iovanna · 1 shared paper, 2025 · strength 0.20
- Ezequiel J. Tolosa · 1 shared paper, 2025 · strength 0.19
- Brooke R Tader · 1 shared paper, 2025 · strength 0.19
- Aleksey V. Matveyenko · 1 shared paper, 2025 · strength 0.19
- Luis F. Flores · 1 shared paper, 2025 · strength 0.19
- Catherine E. Hagen · 1 shared paper, 2025 · strength 0.19
- Kayla C. LaRue-Nolan · 1 shared paper, 2025 · strength 0.19
- Rondell Patrell Graham · 1 shared paper, 2025 · strength 0.19
- Ryan Michael Carr · 1 shared paper, 2025 · strength 0.19
- Christopher L. Pin · 1 shared paper, 2025 · strength 0.19
- David W. Dawson · 1 shared paper, 2025 · strength 0.19
- Brooke D. Paradise · 1 shared paper, 2023 · strength 0.16
- Glancis L. Raja Arul · 1 shared paper, 2023 · strength 0.16
- Daniel Grasso · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.